HomeSLRX • NASDAQ
Salarius Pharmaceuticals Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 895.13K | -11.06% |
Net income | -873.47K | 10.15% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -894.02K | 11.07% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.81M | 46.46% |
Total assets | 6.10M | 57.99% |
Total liabilities | 1.85M | 97.84% |
Total equity | 4.25M | — |
Shares outstanding | 5.86M | — |
Price to book | 0.19 | — |
Return on assets | -59.76% | — |
Return on capital | -130.93% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -873.47K | 10.15% |
Cash from operations | -1.65M | -21.38% |
Cash from investing | -200.00K | — |
Cash from financing | 5.86M | 328.51% |
Net change in cash | 4.01M | 35,727.18% |
Free cash flow | -1.62M | -8.29% |
Previous close
$0.86
Day range
$0.71 - $0.84
Year range
$0.71 - $108.00
Market cap
4.27M USD
Avg Volume
3.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
2
